BofA lowered the firm’s price target on Bath & Body Works to $45 from $54 and keeps a Buy rating on the shares. Management lowered fiscal year sales guidance to down 2% to down 4% from a previous call for flat to down 2% to reflect a slower pace of new customer growth and “while this is disappointing,” the firm sees opportunities to use product innovation and new category launches to drive continued progress on sales, the analyst tells investors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBWI:
- Slashed Sales Forecast Tanks Bath & Body Works Stock (NYSE:BBWI)
- Bath & Body Works narrows FY24 EPS view to $3.06-$3.26 from $3.05-$3.35
- Bath & Body Works sees Q3 EPS 41c-47c, consensus 53c
- Bath & Body Works reports Q2 adjusted EPS 37c, consensus 36c
- Notable companies reporting before tomorrow’s open
Questions or Comments about the article? Write to editor@tipranks.com